Skip to main content
Clinical Trials/EUCTR2010-019804-21-GB
EUCTR2010-019804-21-GB
Active, not recruiting
Phase 1

A randomised, controlled, assessor-blind, clinical investigation of the activity of mosquito® LäuseShampoo compared with Infectopedicul® permethrin 0.5% lotion in the treatment of head lice - Comparing mosquito LauseShampoo with Infectopedicul lotion

Wepa Apothekenbedarf GmbH & Co KG0 sites96 target enrollmentJune 4, 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Infestation by head lice (pediculosis capitis)
Sponsor
Wepa Apothekenbedarf GmbH & Co KG
Enrollment
96
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Wepa Apothekenbedarf GmbH & Co KG

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants aged 2 years and over with no upper age limit.
  • 2\. Participants who upon examination, are confirmed to have at least five live head lice.
  • 3\. Participants who give written informed consent, or if the participant is below 16 years of age whose parent/guardian gives written informed consent to participate in the study.
  • 4\. Participants who will be available for home visits by MEC study team members over the 14 days following first treatment.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. People younger than 2 years
  • 2\. People with a known sensitivity to pyrethroid insecticides like permethrin, chrysanthemums, nuts, soya, or any of the ingredients in mosquito® LäuseShampoo or Infectopedicul® lotion.
  • 3\. People with asthma or a similar respiratory condition.
  • 4\. People with a secondary bacterial infection of the scalp (e.g. impetigo) or who have a long term scalp condition (e.g. psoriasis of the scalp).
  • 5\. People who have been treated with other head lice products within the previous two weeks.
  • 6\. People who have been treated with the antibiotics Co\-Trimoxazole, Trimethoprim or any other medical treatment which could interfere with the study treatment within the previous four weeks, or who are currently taking such a course.
  • 7\. People who have bleached, permanently coloured, or permanent waved their hair within the previous four weeks.
  • 8\. People or parents / guardians not giving written consent or withdrawal of the written consent.
  • 9\. Pregnant or nursing mothers. Any potential participant in menses should confirm that they are not or not likely to be pregnant or are taking an appropriate form of contraception. In case of doubt a urine pregnancy test may be performed prior to entry.
  • 10\. People who have participated in another clinical study within 1 month before entry to this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice
ISRCTN47755726Thornton & Ross Ltd (UK)73
Active, not recruiting
Phase 1
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice - Is Hedrin 4% more effective than Derbac-M for the treatment of head lice?
EUCTR2006-004136-73-GBThornton & Ross Limited
Active, not recruiting
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice - Hedrin Once versus Lyclear against head liceHead louse infestation (pediculosis capitis)MedDRA version: 13.1Level: LLTClassification code 10034214Term: Pediculus capitis (head louse)System Organ Class: 10021881 - Infections and infestations
EUCTR2011-000257-23-GBThornton & Ross Ltd84
Active, not recruiting
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to compare Liceko ® with NIX/Lyclear 1% permethrin crème rinse in the treatment of head lice. - Is Liceko ® more effective than Lyclear against head lice?
EUCTR2011-001892-38-GBPanin S.r.l.44
Completed
Not Applicable
Is Liceko® more effective than Nix® / Lyclear® against head lice?Head louse infestationInfections and InfestationsPediculosis due to Pediculus humanus capitis
ISRCTN45553737Panin S.R.L (Italy)44